ライブ
FierceBiotechADA: Novo’s Lange says ‘jury still out’ on CagriSema amid tough retatrutide comparisonsEndpoints NewsNovartis and Orionis strike second molecular glue deal for $40M upfrontFierceBiotechGLP-1s may combat depression by multiplying a mood-boosting gut microbeBioPharma DiveSanofi stops immune drug trial in latest research setbackEndpoints NewsSonoThera raises $125M for non-viral gene therapy approachBioPharma DiveParabilis sets a record with a $670M biotech IPOFierceBiotechBig Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic deliveryClinical OMICsGLP-1s May Benefit Mental Health Through Gut–Brain AxisClinical OMICsPhase Ib/IIa for Hepatitis B Epigenetic Silencer Shows Best-in-Class PotentialFierceBiotechEthyreal Bio manifests with $101M in pack of biotechs gunning for Amgen’s TepezzaEndpoints NewsShattuck raises $75M; Servier inks neuro ASO pact with n-Lorem FoundationEndpoints NewsBiotech pay analysis: 12 execs with $35M+ M&A golden parachutes
FierceBiotech 2025年12月5日

Chutes & Ladders—Yet another CDER leadership shake-up

Chutes & Ladders—Yet another CDER leadership shake-up

原文
本文は利用できません。元の情報源をご確認ください。